Cargando…

COVID-19 Severity in Hospitalized Pediatric Patients with Atopic Disease

Detalles Bibliográficos
Autores principales:	Timberlake, Dylan, Scherzer, Rebecca, Prince, Benjamin, Grayson, Mitchell
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Mosby, Inc. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849444/ http://dx.doi.org/10.1016/j.jaci.2020.12.302

Ejemplares similares

Severity of COVID-19 in hospitalized patients with and without atopic disease()
por: Timberlake, Dylan T., et al.
Publicado: (2021)

P350 EFFECTS OF ATOPIC DISEASE ON DISEASE SEVERITY IN COVID-19
por: Timberlake, D., et al.
Publicado: (2020)

The evidence is in that asthma is not associated with severe coronavirus disease 2019
por: Timberlake, Dylan T., et al.
Publicado: (2021)

Dendritic Cells, Viruses, and the Development of Atopic Disease
por: Tam, Jonathan S., et al.
Publicado: (2012)

The role of viruses in the development and exacerbation of atopic disease
por: Kumar, Amit, et al.
Publicado: (2009)

Establishing Standardized Documentation for Anaphylaxis Treatment in a Tertiary Care Pediatric Allergy Clinic
por: Kraft, Monica T., et al.
Publicado: (2020)

Apremilast Use for Moderate-to-Severe Atopic Dermatitis in Pediatric Patients
por: Saporito, Rachael C., et al.
Publicado: (2016)

COVID-19 Symptoms Are Attenuated in Moderate-to-Severe Atopic Dermatitis Patients Treated with Dupilumab
por: Ungar, Benjamin, et al.
Publicado: (2022)

The Prevalence of Atopic Diseases Among Pediatric Food Allergic Patients
por: Batais, Waleed, et al.
Publicado: (2023)

Atopic comorbidity has no impact on severity and course of Coronavirus disease 2019 (COVID-19) in adult patients
por: Zarnowski, Julia, et al.
Publicado: (2022)

Predictive biomarker modeling of pediatric atopic dermatitis severity based on longitudinal serum collection
por: Engle, Sarah M, et al.
Publicado: (2021)

265 Evaluating the safety and effectiveness of the COVID-19 vaccination among pediatric atopic dermatitis patients
por: Pakhchanian, H., et al.
Publicado: (2022)

Outcomes of COVID-19 and Vaccination in Patients With Moderate to Severe Atopic Dermatitis Treated With Tralokinumab
por: Blauvelt, Andrew, et al.
Publicado: (2022)

The Posology of Dupilumab in Pediatric Patients With Atopic Dermatitis
por: Kamal, Mohamed A., et al.
Publicado: (2021)

Novel Genetic Discoveries in Primary Immunodeficiency Disorders
por: Redmond, Margaret T., et al.
Publicado: (2022)

Impact of COVID-19 on patients with atopic dermatitis
por: Grieco, Teresa, et al.
Publicado: (2021)

Quality of Life and Disease Severity Are Correlated in Patients with Atopic Dermatitis
por: Kim, Dong Ha, et al.
Publicado: (2012)

Corticosteroid therapy in the treatment of pediatric patients with atopic dermatitis
por: Fröschl, Barbara, et al.
Publicado: (2007)

ACETYLATION PHENOTYPE VARIATION IN PEDIATRIC PATIENTS WITH ATOPIC DERMATITIS
por: Majeed Al-Razzuqi, Rafi A, et al.
Publicado: (2011)

341 Quality of Life in Pediatric Patients with Atopic Dermatitis
por: Campos, Xiomara Lopez
Publicado: (2012)

A caregiver-reported global severity assessment in pediatric atopic eczema: the Comano score
por: Giovannini, Mattia, et al.
Publicado: (2020)

Nail Dystrophy in Patients with Atopic Dermatitis and Its Association with Disease Severity
por: Chung, Bo Young, et al.
Publicado: (2019)

Ocular surface disease is common in moderate‐to‐severe atopic dermatitis patients
por: Achten, Roselie E., et al.
Publicado: (2022)

Treatment of Severe Atopic Dermatitis with Dupilumab in Three Patients with Renal Diseases
por: Foti, Caterina, et al.
Publicado: (2022)

Impact of COVID-19 Pandemic on Patients with Atopic Dermatitis
por: Pourani, M.R., et al.
Publicado: (2022)

Impact of the COVID-19 Pandemic on Atopic Dermatitis Patients
por: Sieniawska, Joanna, et al.
Publicado: (2022)

Severe atopic dermatitis and dupilumab
por: Bernardo, Wanderley, et al.
Publicado: (2023)

COVID-19, quarantine, and atopic dermatitis
por: Patruno, Cataldo, et al.
Publicado: (2020)

Simple Markers for Systemic Inflammation in Pediatric Atopic Dermatitis Patients
por: Batmaz, Sehra Birgül
Publicado: (2018)

IMPACT OF ATOPIC DERMATITIS ON THE QUALITY OF LIFE OF PEDIATRIC PATIENTS AND THEIR GUARDIANS
por: Campos, Amanda Letícia Bezerra, et al.
Publicado: (2017)

Why COVID-19 is Less Severe in Pediatric Patients?
por: Haileamlak, Abraham
Publicado: (2020)

Treating pediatric atopic dermatitis: current perspectives
por: Dimitriades, Victoria R, et al.
Publicado: (2015)

Current and Emerging Therapies in Pediatric Atopic Dermatitis
por: Johnson, Hadley, et al.
Publicado: (2022)

Evaluation of stress and anxiety caused by the coronavirus disease 2019 (COVID-19) pandemic in pediatric radiology
por: Ayyala, Rama S., et al.
Publicado: (2021)

Neopterin Predicts Disease Severity in Hospitalized Patients With COVID-19
por: Bellmann-Weiler, Rosa, et al.
Publicado: (2020)

Effects of disease severity on sleep and quality of life in Taiwanese patients with atopic dermatitis
por: Ho, Pei-Yun, et al.
Publicado: (2022)

IGAxBSA composite for assessing disease severity and response in patients with atopic dermatitis
por: Paller, A.S., et al.
Publicado: (2022)

Impact of the COVID-19 pandemic on adults with moderate-to-severe atopic dermatitis in the Dutch general population
por: Zhang, Junfen, et al.
Publicado: (2021)

Melatonin and sleep disorders in patients with severe atopic dermatitis
por: Jaworek, Andrzej K., et al.
Publicado: (2020)

342 Clinical outcomes in COVID-19 patients with Atopic dermatitis
por: Pakhchanian, H., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0rn6clcb62sedkv7us27r7qc28